Joseph M. Custodio, Ph.D.
Affiliations: | 2008 | Pharmaceutical Sciences and Pharmacogenomics | University of California, San Francisco, San Francisco, CA |
Area:
Pharmacology, Pharmaceutical ChemistryGoogle:
"Joseph Custodio"Parents
Sign in to add mentor| Leslie Z. Benet | grad student | 2008 | UCSF | |
| (Predicting intestinal transporter effects in food -drug interactions and the role of food on drug absorption.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Subramanian R, Wang J, Murray B, et al. (2023) Human pharmacokinetics prediction with an - correction factor approach and drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy for the treatment of HIV-1 infection. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 52: 1020-1030 |
| Custodio JM, Donaldson KM, Hunt HJ. (2020) An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes. Journal of Clinical Pharmacology |
| Zamek-Gliszczynski MJ, Chu X, Cook JA, et al. (2018) ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision. Clinical Pharmacology and Therapeutics |
| Begley R, Das M, Zhong L, et al. (2018) Pharmacokinetics of Tenofovir Alafenamide When Co-administered With Other HIV Antiretrovirals. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Gallant J, Lazzarin A, Mills A, et al. (2017) Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet (London, England) |
| Nguyen T, McNicholl I, Custodio JM, et al. (2016) Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir. Aids Reviews. 18 |